Baihakke, Norsina S.
HRN: 23-99-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/13/2024
09/20/2024
IV
600mg
Q6
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes